Intracellular Therapies
Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS. Learn more
Launch date
Employees
Market cap
CAD10.8b
Enterprise valuation
CAD9.5b (Public information from Sep 2024)
Share price
€67.5 23I.F
New York City New York (HQ)
Authorizing premium user...